NeuroFlo™ catheter

DEVICE2 trials

Sponsors

CoAxia

Conditions

Cerebrovascular Accident

Phase 1

Safety and Efficacy of NeuroFlo in 8-24 Hour Stroke Patients

CompletedNCT00436592

CoAxiaCerebrovascular Accident

Start: 2007-02-28End: 2009-01-31Updated: 2009-02-05

Phase 3

Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke (SENTIS)

CompletedNCT00119717

CoAxiaCerebrovascular Accident

Start: 2005-06-30End: 2010-07-31Updated: 2011-05-18

Related Papers

Favorable vascular profile is an independent predictor of outcome: a post hoc analysis of the safety and efficacy of NeuroFlo Technology in Ischemic Stroke trial.

2013-04-0214 citations

Safety and feasibility of NeuroFlo use in eight- to 24-hour ischemic stroke patients.

2012-01-2014 citations

Partial aortic occlusion for cerebral perfusion augmentation: safety and efficacy of NeuroFlo in Acute Ischemic Stroke trial.

2011-05-1277 citations